SCHEMBL7779713

SCHEMBL7779713

Cn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccncc2)c1C(=O)Nc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
PSMD14 O00487 2/20 0.46
POLB P06746 2/20 0.46
MAPT P10636 2/20 0.46
CACNA1B Q00975 2/20 0.46
APBA1 Q02410 2/20 0.46
RECQL P46063 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
SAE1 Q9UBE0 1/20 0.46
UBA2 Q9UBT2 1/20 0.46
PTGS2 P35354 4/20 0.45
MAPK9 P45984 1/20 0.45
CA1 P00915 4/20 0.44
CA2 P00918 4/20 0.44
CA12 O43570 2/20 0.44
CA9 Q16790 2/20 0.44
CA4 P22748 1/20 0.44
CA7 P43166 1/20 0.44
IKBKE Q14164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7773006 1.00 MEN1 (0.46) MEN1KMT2APSMD14POLBMAPT
SCHEMBL7779950 0.91 PTGS2 (0.48) MEN1KMT2APTGS2PTGS1EPHX2
SCHEMBL7780582 0.91 PTGS2 (0.48) MEN1KMT2APTGS2PTGS1EPHX2
SCHEMBL7780594 0.88 BRAF (0.44) PTGS2CA1CA2CA12CA9
SCHEMBL7779372 0.88 BRAF (0.44) PTGS2CA1CA2CA12CA9
SCHEMBL7779465 0.85 MAPK14 (0.45) KMT2APTGS2CA1CA2CA12
SCHEMBL7773121 0.85 MAPK14 (0.45) KMT2APTGS2CA1CA2CA12
SCHEMBL7773321 0.82 IKBKB (0.46) PTGS2CA1CA2CA12CA9
SCHEMBL7779780 0.82 IKBKB (0.46) PTGS2CA1CA2CA12CA9
SCHEMBL7799176 0.82 CA12 (0.47) PTGS2CA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP claimed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP claimed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US claimed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP claimed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO claimed
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed